hours after transfection. COS-7 cells were incubated with EGF (0.1 g/ml) [biotinylated, complexed to Texas Red-streptoavidin (Molecular Probes, Eugene, OR)] in binding buffer [20 mM Hepes-NaOH ( pH 7.5), 130 mM NaCl, and 0.1% bovine serum albumin] at 4°C for 60 min. Internalization of EGF was allowed by incubation in Dulbecco's modified Eagle's medium at 37°C for 10 min, then excess EGF was removed with 0.2 M AcOH ( pH 2.5) and 0.5 M NaCl at 4°C for 5 min. Cells were fixed in 3.7% formaldehyde, permeabilized with 0.2% Triton X-100, and immunostained with a polyclonal antibody to myc (Santa Cruz Biotechnology, Santa Cruz, CA) and fluorescein isothiocyanate-conjugated antibody to rabbit (Organon Teknika, Boxtel, Netherlands). Internalization of EGF was observed by confocal microscopy (Bio-Rad). 37. We thank Y. Watanabe (Ehime University, Japan) for providing us with various synthetic phosphoinositides.
Adaptor protein 180 (AP180) and its homolog, clathrin assembly lymphoid myeloid leukemia protein (CALM), are closely related proteins that play important roles in clathrin-mediated endocytosis. Here, we present the structure of the NH 2 -terminal domain of CALM bound to phosphatidylinositol-4,5-bisphosphate [PtdIns(4,5)P 2 ] via a lysine-rich motif. This motif is found in other proteins predicted to have domains of similar structure (for example, Huntingtin interacting protein 1). The structure is in part similar to the epsin NH 2 -terminal (ENTH) domain, but epsin lacks the PtdIns(4,5)P 2 -binding site. Because AP180 could bind to PtdIns(4,5)P 2 and clathrin simultaneously, it may serve to tether clathrin to the membrane. This was shown by using purified components and a budding assay on preformed lipid monolayers. In the presence of AP180, clathrin lattices formed on the monolayer. When AP2 was also present, coated pits were formed.
Budding of clathrin-coated vesicles is a process by which cells package specific cargo into vesicles in a regulated fashion (1) (2) (3) . Important functions are the uptake of nutrients, the regulation of receptor and transporter numbers on the plasma membrane, and the recycling of synaptic vesicles. AP180 and AP2 are both major components of clathrin coats. AP2 is a heterotetrameric complex that binds to phosphoinositides in the membrane and to the cytoplasmic domains of membrane proteins destined for internalization (1, 3, 4) . AP2 binds clathrin and can stimulate clathrin cage assembly in vitro (5, 6) . It also interacts with a range of cytoplasmic proteins including AP180 (7) . Like AP2, AP180 also binds directly to clathrin and can stimulate clathrin cage assembly in vitro, limiting the size distribution of the resulting cages (8) (9) (10) (11) . The related proteins, CALM (AP180-2, a close homolog of synaptic AP180), LAP (the Drosophila AP180 homolog), and UNC-11 (the Caenorhabditis elegans homolog), are all implicated in clathrin-coated vesicle endocytosis (12, 13) . CALM was identified and named because of its homology to AP180 and to reflect its involvement in t(10;11) chromosomal translocations found in various leukemias (14) . Disruptions of the LAP and Unc-11 genes impair clathrin-dependent recycling of synaptic vesicles, resulting in fewer vesicles of more variable size. The NH 2 -terminal domain of AP180 (AP180-N) shows the highest degree of conservation across AP180 homologs, and binds to inositol polyphosphates (10, 15, 16) , whereas the COOHterminal domain contains the putative clathrin-and AP2-binding sites (Fig. 1A) .
When expressed in COS-7 fibroblasts, both full-length AP180 and AP180-C (residues 530 to 915) inhibited uptake of epidermal growth factor (EGF) and transferrin (17) (Fig. 1B) , as is the case for CALM (18). Clathrin was redistributed in transfected cells, and we noted fewer coated pits per unit of cell surface-membrane length (8% of control, Fig. 1C ). This showed that endocytosis was inhibited by blocking clathrin-coated pit formation, consistent with the ability of the COOH-terminus to bind clathrin and to stimulate cage assembly in vitro (8-11). However, AP180-N overexpression did not inhibit EGF or transferrin uptake (Fig. 1B) .
It had no apparent protein-binding partners but is more localized to the plasma membrane, consistent with binding to polyphosphoinositides (15, 16) .
To probe the molecular basis of phosphoinositide interactions, we solved the structure of the NH 2 -terminal domain from the close AP180 homolog, CALM, at 2 Å resolution (19, 20) (crystals of AP180-N did not diffract well). There were nine ␣ helices forming a solenoid structure (Fig. 2) . This is reminiscent of other protein families formed from a superhelix of ␣ helices such as the armadillo (21) and tetratricopeptide repeat (22) domains, but it is most similar to the ENTH domain of epsin (23) (Fig. 2B) . The first seven helices of epsin superimposed well on those of CALM. In epsin, however, the final ␣8 helix folded back across the others, whereas in CALM the final three long helices continued the solenoidal pattern. Because of the high sequence homology of CALM-N and AP180-N (81% sequence identity) (Fig.  2) , we can safely assume that the NH 2 -terminal domain of AP180 has the same structure.
X-ray data were collected at 2 Å resolution from CALM-N crystals soaked in a series of inositol phosphates and phospholipids. Fig. 2) : Typical ligand-binding sites on proteins lie in a pocket or groove, but this site is on the surface, with the phosphates perched on the tips of the side chains of three lysines and a histidine, like a ball balanced on the fingertips. In all ligands, only the two phosphates were well ordered and contacted the protein. The cluster of lysines and histidine formed a marked positively charged patch on the surface (Fig. 2C) , appropriate for a phosphate-binding protein.
Database searches with the AP180-N/ CALM-N identified several classes of related sequences (Fig. 2H) . First, there were the members of the AP180 family itself, with a conserved NH 2 -terminal domain, having PtdIns(4,5)P 2 -binding motifs, which we identified from the observed binding in the crystal, K(X) 9 †To whom correspondence should be addressed. E-mail: pre@mrc-lmb.cam.ac.uk, hmm@mrc-lmb.cam.ac.uk binding motifs (7, 25) and Asn-Pro-Phe (NPF) motifs, which bind to Eps15 homology (EH) domains (26) (see Fig. 1A ). Second, there were other proteins similar to AP180, containing the PtdIns(4,5)P 2 -binding motifs, but having unrelated COOH-terminal regions. Of these proteins, Huntingtin interacting protein 1 (HIP1) and SLA2p have actinbinding regions in their COOH-termini. Third, there were the epsin-related proteins; these showed a lower sequence homology in the NH 2 -terminus but shared the same structure for at least the first 140 residues (Fig. 2) . They lack completely the PtdIns(4,5)P 2 -binding motif, but have a signature (D/E)PW motif in the loop connecting ␣1 to ␣2. According to our predictions, ␣-adaptin (which has no sequence homology to AP180) has a PtdIns(4,5)P 2 -binding motif near its NH 2 -terminus between the first two predicted helices. Indeed, a fragment from this region of the protein has been shown to bind PtdIns(4,5)P 2 (4) . Specificity of the phosphoinositide interaction with AP180-N and CALM-N was tested by sedimentation assays using liposomes or lipid tubules (19, 27, 28) . Tubules containing 10% PtdIns(4,5)P 2 efficiently sedimented AP180-N and CALM-N with the same apparent affinity (K M values of 4.6 Ϯ 0.7 M and 5.8 Ϯ 1.7 M, respectively) but mutations in the PtdIns(4,5)P 2 motif (KKK-EEE) abolished sedimentation (Fig. 3A) . AP180-N was likewise sedimented with liposomes containing 10% PtdIns(4,5)P 2 , but not with liposomes when replaced with 10% phosphatidylserine (PtdSer), or 10% PtdIns, or 10% PtdIns(3,4)P 2 and less efficiently with liposomes containing 10% PtdIns(4)P or 10% PtdIns(3,5)P 2 or 10% PtdIns(3,4,5)P 3 (Fig.  3B) . Full-length AP180 binds to lipid tubules or liposomes containing PtdIns(4,5)P 2 with characteristics similar to those of AP180-N; however, a mutant in the PtdIns(4,5)P 2 -binding motif (KKK-EKE) does not (Fig. 3C) .
Combinations of full-length AP180, AP2, and clathrin were then tested in sedimentation assays with PtdIns(4,5)P 2 -containing liposomes. AP2 was sedimented both in the presence and absence of AP180 (Fig.  3C) . Clathrin only sedimented in the presence of AP180 [but not the PtdIns(4,5)P 2 -binding motif mutant], and then it associated preferentially with the lipid-bound AP180. Incubation of AP180, AP2, and clathrin resulted in the sedimentation of all components, and the clathrin in the pellet was resistant to 1% Triton X-100 treatment, implying a degree of polymerization (addition of Triton X-100 has been used as a purification step in the isolation of clathrin coats). Specificity of sedimentation was confirmed by using a number of controls including the absence of liposomes (Fig.  3C) . 
The recruitment of clathrin by AP180 was further investigated by electron microscopy to visualize clathrin lattice and cage formation. In the presence of AP180 and clathrin, latticelike structures formed on the surface of lipid monolayers (29) (Fig. 4A) . Addition of AP2 resulted in the formation of more distinct electron-dense areas of clathrin assembly (Fig. 4B) . Single-angle platinum shadowing of negatively stained grids showed that in the absence of AP2 the lattice was predominantly flat (Fig. 4C) . Invaginated coated buds were formed in the presence of AP2 (Fig. 4D) . The diameter was well within the expected size range for brain-derived coated vesicles. In the absence of AP180, no detectable intermediates were visible by electron microscopy. When PtdIns(4,5)P 2 was replaced by PtdIns, the flat clathrin lattices were no longer seen (Fig. 4E) .
Our experiments demonstrate that the minimal requirements for the initial stage of coated pit invagination are clathrin, AP180, AP2, and PtdIns(4,5)P 2 -containing membranes. However, with these components, the pits do not invaginate completely, even in the presence of excess clathrin. AP180 concentrates clathrin on the membrane, and AP2s stimulate curved lattice assembly, consistent with their coat assembly activity (6 ) . On a more general note, we show that the AP180 NH 2 -terminal domain is a PtdIns(4,5)P 2 -binding domain responsible for membrane localization of AP180, and we propose that similar domains found in other proteins will also recruit them specifically to PtdIns(4,5)P 2 -rich membranes. 
Note added in proof:
It has been reported (44) that AP180 and its clathrin-binding domain inhibit transferrin endocytosis in HeLa and Cos cells and redistribute endogenous clathrin in HeLa cells. docytosis was measured by assaying EGF and transferrin uptake (32) on an MRC 1024 confocal microscope. Antibodies used for immunofluorescence are as follows: A14 (MYC-tag), Ra24 (AP180-N), and X-22 (clathrin), and secondary antibodies were conjugated with Texas Red or Cy-5. Transfected cells were compared with untransfected controls in their immediate vicinity. Blocked cells were defined as those transfected cells in which EGF or transferrin uptake was Ͻ20% that of untransfected controls. Blocked cells were expressed as a percentage of the total number of transfected cells, sampled in multiple fields and in multiple separate experiments. For immuno-electron microscopy of fibroblasts, cells either expressing the human transferrin receptor alone (cloned into pRK5), or coexpressing this with AP180-C were incubated at 4°C with B3/25 (antibody against human transferrin) conjugated to 10 nm gold for 90 min, rinsed, fixed, and processed as described (33) . Sections were analyzed morphometrically by using standard techniques. 18. F. Tebar, S. K. Bohlander, A. Sorkin, Mol. Biol. Cell 10, 2687 (1999). 19. AP180-N and CALM-N (residues 1 to 289) and mutants thereof were expressed as NH 2 -terminal glutathione S-transferase fusion proteins in BL21 cells. Protein was expressed overnight at 22°C and purified from extracts by passage over a glutathione-agarose column. The protein was cleaved with thrombin in 20 mM Hepes, pH 7.4, 150 mM NaCl, and 4 mM dithiothreitol (DT T). AP180-N and CALM-N were purified further by passage over Q-Sepharose followed by S200 gel filtration. For crystallization trials, AP180-N was concentrated to 40 mg/ml and CALM-N was concentrated to 16 mg/ml. For sedimentation assays, protein was typically used at 1 mg/ml. Full-length His 6 -tagged rat brain AP180 was purified from baculovirus-infected Sf9 cells 48 hours after infection. Protein was purified on a Ni-nitriloacetic acid (Ni-NTA) column, dialyzed into 20 mM Hepes, pH 7.4, 75 mM NaCl, and 4 mM DT T with protease inhibitors and bound to a Q-Sepharose column. Protein was eluted using a NaCl gradient from 75 to 300 mM. (27) . Pellets (P) and supernatants (S) were separated by centrifugation. In AP180mut, lysines 38 and 40 were changed to glutamic acids. Although AP2 alone sedimented approximately as efficiently as AP180, it was not capable of sedimenting together with clathrin, possibly because of a requirement for cargo and/or oligomerization. Averages of at least three experiments are shown in the bar graph. Experiments contained 0.05 mg/ml AP180, 0.05 mg/ml AP2, 0.025 mg/ml clathrin in a final volume of 100 l. All gels were stained with Coomassie Blue. 
